Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frings is a German process engineering and plant manufacturing company that designs and supplies fermentation, bioprocess, filtration, and related upstream and downstream systems. The company serves biotechnology, pharmaceutical, food, chemical, and environmental markets, with a particular focus on aerobic fermentation and gas/liquid reaction technology. Its offering includes laboratory bioreactors, pilot systems, industrial fermenters, membrane plants, dosing systems, biomass separation, utilities, and wastewater treatment equipment. Frings appears to be an operating equipment and technology supplier rather than a drug developer, so it does not have a traditional therapeutic pipeline. The business is best understood as a commercial industrial technology provider with relevance to bioprocessing and industrial biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frings.